Changes

* '''Inflammatory mediators''', by:

* '''Inflammatory mediators''', by:

** Inhibiting cyclo-oxygenase, leading to a decrease in prostanoid levels.

** Inhibiting cyclo-oxygenase, leading to a decrease in prostanoid levels.

** Inhibiting phosphlipase-A2, reducing conversion of phospholipid to arachidonate and therefore mediator production.

** Inhibiting phospholipase-A2, reducing conversion of phospholipid to arachidonate and therefore mediator production.

** Decreasing generation of inflammatory cytokines.

** Decreasing generation of inflammatory cytokines.

** Decreasing histamine release.

** Decreasing histamine release.